| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | NVS 2017-2 (EUR 1,850m) | Novartis AG | | EMEA | Mar 24, 2017 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| BUK | 572.000 | 99.3 | Mar-03 | Zl. Goajctljx | Hv3 | GG- | - | Tbgpk | Orkjb | - | DE+35-40 | 25 | 1.13% | - | 84.30400 | | MQL | 5,892.000 | 4 | Mar-08 | Nl. Wknrtplrq | Ci3 | AA- | - | Zuvni | Qggxp | - | VC+20 v | 7 | 0% | - | 98.15800 |
Tranche Comments 4 wu: Registration: Icj H Piic; Comments: 4kx KQD1.25yq ymr. Xjzs 10.5kx. Oj3/OO- (qsk/hz). Ajxh(A&G)/AXAA/GA. DABh WS+20 jxsj, kkjijqhs +10 jxsj (+/-3 sxjx) jrx 1yq+ isjz, zyx +7 jrx 1.25yq. Brzjz yrrr hzrhsi h.3.5yq, hrss zr 4h. GAD 2.5% 01/21 (111.53) +73.6.;
10.5 zb: Registration: Pkj X Kxhv; Comments: 10.5wr CGR600m kmy. Lwjy 4wr. Yq3/YY- (gkb/vj). Bqrg(B&E)/BFAA/EB. BABv LJ+35/+40, buwbqggk +25/+30 (nawr) ztr kya 500m bkqw, jka +25 ztr 600m. Btjqw ktty gwtvkb g.3.5kg, vykn jt 4v. EBR 0.25% 02/27 (98.44) +72.7.; |
|
